Goldman Sachs raises Calumet stock price target to $57 on margins
Goldman Sachs raised its price target on Calumet Specialty Products Partners (CLMT) to $57 from $45, citing strong margins and balance sheet strength. The stock has surged 182% year-to-date. CLMT reported Q2 2026 revenue of $1.44B, beating estimates, but posted a loss of $1.09 per share. S&P upgraded its credit rating to 'B-' from 'CCC+'.
How this was made
The 30-second read
Why it matters
For traders, the actionable signal is the PT revision and the specific drivers Goldman emphasizes (base oil and renewable diesel margins, deleveraging, and MaxSAF ramp). However, the article does not introduce new company fundamentals beyond referencing prior results and upcoming earnings focus.
Market read
This is a modest sentiment catalyst for CLMT tied to margin expectations and the MaxSAF expansion narrative, with near-term attention on earnings-call commentary.
What to watch
MaxSAF ramp execution and capital spend implications are flagged as key uncertainties, which can dominate the margin thesis into the earnings call.
Background
The piece is an analyst note summary: Goldman lifts Calumet’s price target and reiterates a Neutral stance while monitoring the MaxSAF production ramp.
Ticker impact
Goldman Sachs raised Calumet Specialty Products Partners’ price target to $57 from $45 while keeping a Neutral rating, citing base oil and renewable diesel margin exposure plus MaxSAF ramp monitoring.
Likely modest upside bias as traders price in improved margin expectations, tempered by the Neutral rating and focus on upcoming earnings commentary.
The article provides a concrete PT change and thesis (margins, MaxSAF ramp, deleveraging), but it is still an analyst action rather than a new company disclosure.
Market effects
Highlights sensitivity of specialty refining and renewable diesel/SAF-linked names to base oil and renewable diesel margin spreads.
No clear regional catalyst beyond US-listed energy/refining sentiment.
Renewable diesel and sustainable aviation fuel margin expectations can influence broader energy transition trade narratives.
Counterpoint
The Neutral rating and note that analysts do not expect profitability this year suggest the PT increase may not translate into near-term earnings power.
Key entities
- companyCalumet Specialty Products Partners
NASDAQ-listed specialty refining and renewable diesel/SAF exposure; subject of Goldman’s price-target raise and monitoring of MaxSAF ramp.
- analyst_firmGoldman Sachs
Raised Calumet’s price target to $57 from $45 and maintained a Neutral rating, citing margin exposure and balance-sheet strength.
